| |
|
|
|
Aytu Bioscience Inc  
|
|
1.18 -0.02 (-0.02%) |
09-25 16:00 |
|
Open: |
1.17 |
Pre close: |
1.2 |
Target:
|
1.62
|
|
High: |
1.18 |
Low: |
1.16 |
Resistance:
|
1.39
1.62
|
|
Volume: |
1,542,984 |
Market Cap: |
142M |
Support:
|
1.09
0.90
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.25
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
1.17  |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
1.38 |
Stochastic Oscillator |
%K(14,3):
|
65.31 |
|
MA(250): |
1.18 |
%D(3): |
73.02 |
|
Average Volume(K) |
3-Month: |
454131
|
52-Week |
High:
|
2.99 |
|
10-Days: |
407547 |
Low: |
0.34 |
|
RSI |
RSI(14):
|
45.64 |
Change(%): |
-2.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.249 |
Return on Equity (ttm) |
-49.2 |
Shares Out. (M) |
120.61 |
|
EPS Est. Current Year |
-29.400 |
Return on Assets (ttm) |
-12.1 |
Shares Float (M) |
116.08 |
|
EPS Est. Next Year |
-12.800 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.24 |
|
EPS Est. Next Quarter |
-7.400 |
Qtrly Rev. Growth |
243.0 |
% Held by Institutions |
12.01 |
|
Forward EPS |
-3.480 |
Gross Profit (p.s.) |
0.042 |
Shares Short (K) |
5330 |
|
Book Value (p.s.) |
0.850 |
EBITDA (p.s.) |
-0.121 |
P/E |
-4.74 |
|
Sales Per Share |
0.120 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.39 |
|
Profit Margin |
-172.62 |
Operating Cash Flow
(M) |
-24.08 |
P/S |
9.82 |
|
Operating Margin |
-131.68 |
Levered Free Cash Flow
(M) |
4.09 |
P/CF |
-5.91 |
|
|
|
|
|
|
